Bigul

GODREJ CONSUMER PRODUCTS LTD. - 532424 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sirs, Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR/ 2022 / 8 dated January 25, 2022, we enclose the details of 'Letter(s) of Confirmation' issued by the Company to its shareholders, in lieu of share certificate(s) reported as lost by them.
17-05-2023
Bigul

GODREJ CONSUMER PRODUCTS LTD. - 532424 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sirs, Pursuant to Regulation 39(3) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the details about loss of share certificates.
16-05-2023

Buy Godrej Consumer Products; target of Rs 1150: Sharekhan

Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated May 11, 2023.
13-05-2023
Bigul

Godrej Consumer sees volume-led growth in FY24, price-led growth in FY25

The company is also planning to focus on India and invest more domestically while simplifying its international operations.
12-05-2023
Bigul

GODREJ CONSUMER PRODUCTS LTD. - 532424 - Announcement under Regulation 30 (LODR)-Investor Presentation

We attach herewith the presentation made at the Sell Side Analyst meet held today. You are requested to take the above information on your record.
11-05-2023

Godrej Consumer Products gains on Q4 numbers, analysts say turnaround story is fully underway

For FY24, the company expects to maintain volume growth momentum. The management is targeting high single-digit volume growth for the fiscal and 25 percent margins in the recently acquired Park Avenue
11-05-2023
Bigul

GODREJ CONSUMER PRODUCTS LTD. - 532424 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Dear Sirs, In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions on a consolidated basis, in the prescribed format, for the half year ended March 31, 2023. The above information is also being uploaded on the Company's website, viz. www.godrejcp.com Please take the same on record.
10-05-2023
Bigul

Q4FY23 Quarterly Result Announced for Godrej Consumer Products Ltd.

Personal products company Godrej Consumer Products announced Q4FY23 results: GCPL clocks sales of Rs 3,172 crore with double-digit growth of 10% and reported net profit growth of 24% Q4FY23 consolidated sales grew by 10% in INR led by volume growth of 6%; constant currency growth of 14% YoY India business sales grew by 12% YoY led by volume growth of 11% Indonesia sales grew by 8% in INR and 5% in constant currency terms, YoY; ex-Hygiene growth of 14% and 11% in INR and constant currency respectively Africa, USA, and Middle East sales grew by 6% in INR and 8% in constant currency terms YoY Latin America & SAARC sales declined by 3% in INR and grew by 64% in constant currency terms YoY Q4FY23 consolidated EBITDA grew by 32% YoY Q4FY23 consolidated net profit grew by 29% YoY (without exceptional items and one-offs) Commenting on the business performance of Q4FY23, Sudhir Sitapati, Managing Director and CEO, GCPL, said: "We had a strong end to the year with volume-led double-digit sales growth in Q4FY23. Consolidated sales grew by 10% in INR terms and 14% in constant currency terms. We have continued to witness sequential improvement in volume growth with a 6% YoY increase in Q4. The performance was broad-based with India Branded business delivering stellar volume growth of 13%, led by double-digit volume growth in both Home Care and Personal Care. In Indonesia, our core business performance continued to improve with ex-Hygiene growth of 11% in constant currency terms. The double-digit growth trajectory in our Africa, USA, and Middle East business was temporarily impacted by the election and demonetisation in Nigeria. Our quality of profits has also been improving with Consolidated Gross Margin expansion of 180 bps quarter-on-quarter, 340 bps YoY and EBITDA Margin improvement of 360 bps YoY. We grew EBITDA by 32% YoY along with continued working media investments which saw a growth of 20% YoY. Our net profit without exceptional and one-offs increased by 29% year-on-year. We expect to build on the current momentum and deliver volume-led growth along with upfront marketing investments and improvement in profitability. We continue to have a strong balance sheet. We are on track in our journey to reduce wasted costs and are deploying this to drive profitable and sustainable volume growth across our portfolio through category development. We remain committed to our purpose of bringing the goodness of health and beauty to consumers in emerging markets." Result PDF
10-05-2023
Next Page
Close

Let's Open Free Demat Account